AliveCor KardiaMobile (2017)
The FDA cleared KardiaMobile, a pocket-sized single-lead ECG that pairs with a smartphone app to detect atrial fibrillation. It was the first FDA-cleared personal ECG accessible without a prescription.
KardiaMobile became a widely used consumer ECG device.
Established the model of FDA-cleared algorithmic analysis on hardware the user provides, a direct precursor to ZBPro's approach.
Both products rely on software algorithms to interpret ECG data on hardware the user provides, rather than clinical-grade recorders.
